牛牛AI助理已提取核心訊息
On January 2, 2024, T2 Biosystems, Inc., a company registered in Delaware and listed on The Nasdaq Capital Market under the trading symbol TTOO, announced the immediate resignation of Thierry Bernard from his position as a Class II director. Bernard's resignation, detailed in a written letter, was not due to any disputes or disagreements with the company or its management but was attributed to other personal commitments. Bernard was a member of the company's Audit Committee prior to his departure. The Audit Committee will continue with David Elsbree as Chairman, alongside members Ninfa Saunders and Seymour Liebman.
On January 2, 2024, T2 Biosystems, Inc., a company registered in Delaware and listed on The Nasdaq Capital Market under the trading symbol TTOO, announced the immediate resignation of Thierry Bernard from his position as a Class II director. Bernard's resignation, detailed in a written letter, was not due to any disputes or disagreements with the company or its management but was attributed to other personal commitments. Bernard was a member of the company's Audit Committee prior to his departure. The Audit Committee will continue with David Elsbree as Chairman, alongside members Ninfa Saunders and Seymour Liebman.
2024年1月2日，在特拉華州註冊並在納斯達克資本市場以交易代碼TTOO上市的公司T2 Biosystems, Inc. 宣佈蒂埃裏·伯納德立即辭去二類董事的職務。伯納德的辭職在一封書面信中詳述，不是由於與公司或其管理層有任何爭議或分歧，而是由於其他個人承諾所致。伯納德在離職前是公司審計委員會的成員。審計委員會將繼續由大衛·埃爾斯布里擔任主席，成員寧法·桑德斯和西摩·利布曼也將出席。
2024年1月2日，在特拉華州註冊並在納斯達克資本市場以交易代碼TTOO上市的公司T2 Biosystems, Inc. 宣佈蒂埃裏·伯納德立即辭去二類董事的職務。伯納德的辭職在一封書面信中詳述，不是由於與公司或其管理層有任何爭議或分歧，而是由於其他個人承諾所致。伯納德在離職前是公司審計委員會的成員。審計委員會將繼續由大衛·埃爾斯布里擔任主席，成員寧法·桑德斯和西摩·利布曼也將出席。
有用
沒用